(Q38445683)

English

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology

scientific article published on 23 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

cholangiocarcinoma

0 references

1 reference

based on heuristic

inferred from title

Christine Sempoux

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

I Borbath

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Ceratti

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

C Verslype

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Demols

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

T Delaunoit

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

S Laurent

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Deleporte

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

P Vergauwe

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Van Maanen

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

E Van Cutsem

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

J L Van Laethem

12

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Belgian Group of Digestive Oncology

13

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

23 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

2824-2829

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Cholangiocarcinoma: Current concepts and insights

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Changing international trends in mortality rates for liver, biliary and pancreatic tumours

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Liver transplantation for unresectable perihilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Genetics of biliary tract cancers and emerging targeted therapies

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Thrombotic microangiopathy with targeted cancer agents

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT337

21 January 2018

Identifiers

10.1093/ANNONC/MDT337

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38445683&oldid=2193758266"